Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 90041 - 90060 out of 495987 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Canada | (M05BX05) burosumab (adm: P) | Crysvita | Liq/Liq. SC 20 mg/mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
Hypophosphatemia, Familial;Hypophosphatemic Rickets, X-Linked Dominant;Osteomalacia | KKI |
| Canada | (M05BX05) burosumab (adm: P) | Crysvita | Liq/Liq. SC 30 mg/mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
Hypophosphatemia, Familial;Hypophosphatemic Rickets, X-Linked Dominant;Osteomalacia | KKI |
| Canada | (M05BX06) romosozumab (adm: P) | Evenity | Liq/Liq. SC 105 mg / 1.17 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Osteoporosis | AGA |
| Canada | (M09AX07) nusinersen (adm: P) | Spinraza | Liq/Liq. INT 2.4 mg/mL,Millilitre / millilitre | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | BIG |
| Canada | (M09AX09) onasemnogene abeparvovec | Zolgensma | Liq/Liq. IV 2 x 10 13 vg/mL,Unit / unité | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NVR |
| Canada | (M09AX10) risdiplam (adm: O) | Evrysdi | Pws/Pd.S Orl 0.75 mg/mL,Bottle / bouteille | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | HLR |
| Canada | (N01BB02) lidocaine | Xylocaine Ointment 5% | Ont/Ong. Top 5%,gram / gramme | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | APN |
| Canada | (N01BB09) ropivacaine | Naropin | Liq/Liq. Prt 5 mg/mL,Millilitre / millilitre | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | APN |
| Canada | (N01BB09) ropivacaine | Naropin | Liq/Liq. Prt 10 mg/mL,Millilitre / millilitre | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | APN |
| Canada | (N02CC01) sumatriptan (adm: N) | Imitrex | Spr/Vap. Nas 5 mg,Dose / dose | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GSK |
| Canada | (N02CC01) sumatriptan (adm: N) | Imitrex | Spr/Vap. Nas 20 mg,Dose / dose | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GSK |
| Canada | (N02CC03) zolmitriptan | Zomig | Spr/Vap. Nas 2.5 mg,Dose / dose | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | XPI |
| Canada | (N02CC03) zolmitriptan | Zomig Nasal | Spr/Vap. Nas 5 mg,Dose / dose | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | XPI |
| Canada | (N02CD02) galcanezumab (adm: P) | Emgality (autoinjector) | Liq/Liq. SC 120 mg/mL,Autoinjector / auto-injecteur | Ex-factory price without vat |
$0-0 |
$0-0 |
Migraine Disorders | LIL |
| Canada | (N02CD02) galcanezumab (adm: P) | Emgality (prefilled syringe) | Liq/Liq. SC 120 mg/mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Migraine Disorders | LIL |
| Canada | (N02CD03) fremanezumab (adm: P) | Ajovy (autoinjector) | Liq/Liq. SC 225 mg / 1.5 mL,Autoinjector / auto-injecteur | Ex-factory price without vat |
$0-0 |
$0-0 |
Migraine Disorders | TEV |
| Canada | (N02CD03) fremanezumab (adm: P) | Ajovy (prefilled syringe) | Liq/Liq. SC 225 mg / 1.5 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Migraine Disorders | TEV |
| Canada | (N02CD05) eptinezumab (adm: P) | Vyepti | Liq/Liq. IV 300 mg / 3 mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
Migraine Disorders | VLH |
| Canada | (N02CD05) eptinezumab (adm: P) | Vyepti | Liq/Liq. IV 100 mg/mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
Migraine Disorders | VLH |
| Canada | (N03AB02) phenytoin (adm: O) | Dilantin 30 | Sus/Susp. Orl 30 mg / 5 mL,Millilitre / millilitre | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BGP |
Pages
